Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review

Detalles Bibliográficos
Autores principales: Nishi, Kentaro, Ogura, Masao, Tamai, Naotaka, Gima, Masafumi, Ide, Kentaro, Koinuma, Goro, Kamei, Koichi, Ito, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446570/
https://www.ncbi.nlm.nih.gov/pubmed/36064710
http://dx.doi.org/10.1186/s12969-022-00736-0
_version_ 1784783670405496832
author Nishi, Kentaro
Ogura, Masao
Tamai, Naotaka
Gima, Masafumi
Ide, Kentaro
Koinuma, Goro
Kamei, Koichi
Ito, Shuichi
author_facet Nishi, Kentaro
Ogura, Masao
Tamai, Naotaka
Gima, Masafumi
Ide, Kentaro
Koinuma, Goro
Kamei, Koichi
Ito, Shuichi
author_sort Nishi, Kentaro
collection PubMed
description
format Online
Article
Text
id pubmed-9446570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94465702022-09-07 Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review Nishi, Kentaro Ogura, Masao Tamai, Naotaka Gima, Masafumi Ide, Kentaro Koinuma, Goro Kamei, Koichi Ito, Shuichi Pediatr Rheumatol Online J Correction BioMed Central 2022-09-05 /pmc/articles/PMC9446570/ /pubmed/36064710 http://dx.doi.org/10.1186/s12969-022-00736-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Nishi, Kentaro
Ogura, Masao
Tamai, Naotaka
Gima, Masafumi
Ide, Kentaro
Koinuma, Goro
Kamei, Koichi
Ito, Shuichi
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title_full Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title_fullStr Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title_full_unstemmed Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title_short Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
title_sort correction: successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-mda5 antibody-positive juvenile dermatomyositis: a case report and literature review
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446570/
https://www.ncbi.nlm.nih.gov/pubmed/36064710
http://dx.doi.org/10.1186/s12969-022-00736-0
work_keys_str_mv AT nishikentaro correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT oguramasao correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT tamainaotaka correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT gimamasafumi correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT idekentaro correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT koinumagoro correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT kameikoichi correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview
AT itoshuichi correctionsuccessfulrituximabtreatmentforsevererapidlyprogressiveinterstitiallungdiseasewithantimda5antibodypositivejuveniledermatomyositisacasereportandliteraturereview

Ejemplares similares